CDMO News
AsymBio Inaugurates New CDMO Facility in Shanghai’s Fengxian District
AsymBio, the CDMO subsidiary of Asymchem Laboratories, has officially launched its new manufacturing base in Fengxian, Shanghai. The 120,000-square-metre facility will provide late-stage clinical and commercial manufacturing services for antibodies and bioconjugates. The first phase of the site, now operational,
4 March 2025